Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator

Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California.

OBJECTIVES. This study was conducted to evaluate criteria for discrimination of ventricular tachycardia from atrial fibrillation and sinus tachycardia in a tiered-therapy cardioverter-defibrillator (Medtronic PCD). BACKGROUND. Interval stability algorithms discriminate ventricular tachycardia from atrial fibrillation. Onset algorithms discriminate ventricular tachycardia from sinus tachycardia. Neither has been validated clinically. METHODS. The stability criterion requires that a ventricular tachycardia interval not vary from any of the three previous intervals by more than the programmable stability value. The onset criterion detects initiation of ventricular tachycardia only if the ratio of an interval to the mean of four previous intervals is less than a programmed onset ratio and either the second or third preceding interval exceeds the ventricular tachycardia detection interval. We evaluated these criteria in 100 patients at electrophysiologic study and exercise testing (65 patients) and during a mean (+/- SD) follow-up of 16.2 +/- 7.9 months. The PCDs were programmed to tiered therapy in 54 patients. In the remaining 46 patients, the PCD's memory for detected ventricular tachycardia was used to study the specificity of the chosen onset criterion for rejecting sinus tachycardia. We used stored intervals preceding appropriate (n = 99) and inappropriate (n = 54) detections to test a new onset criterion that was less sensitive to a single index interval. RESULTS: Programmed stability of 40 ms decreased detection of induced atrial fibrillation by 95% (20 patients), paroxysmal atrial fibrillation by 95% (6 patients) and chronic atrial fibrillation by 99% (9 patients); all episodes of spontaneous (n = 877) and induced (n = 339) ventricular tachycardia were detected. A programmed onset ratio of 87% rejected sinus acceleration (98%) but caused underdetection of 0.5% of ventricular tachycardias. The onset criterion permitted inappropriate detection of premature ventricular complexes during sinus tachycardia, but the new criterion reduced these inappropriate detections by 98%. CONCLUSIONS. The PCD's onset and stability criteria reduced inappropriate detection of atrial fibrillation and sinus acceleration while detecting 99.5% of ventricular tachycardias.

This article has been cited by other articles:

				S. Tzeis, G. Andrikopoulos, C. Kolb, and P. E. Vardas Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks Europace, August 15, 2008; (2008) eun205v1. [Abstract] [Full Text] [PDF]

				A. K. Gehi, D. Mehta, and J. A. Gomes Evaluation and Management of Patients After Implantable Cardioverter-Defibrillator Shock JAMA, December 20, 2006; 296(23): 2839 - 2847. [Abstract] [Full Text] [PDF]

				R. Corbisiero, M. A. Lee, D. R. Nabert, J. A. Coman, D. J. Breiter, M. Schwartz, E. Mckittrick, and Y. Zhang Performance of a new single-chamber ICD algorithm: discrimination of supraventricular and ventricular tachycardia based on vector timing and correlation Europace, December 1, 2006; 8(12): 1057 - 1061. [Abstract] [Full Text] [PDF]

				A. Kadish and M. Mehra Heart Failure Devices: Implantable Cardioverter-Defibrillators and Biventricular Pacing Therapy Circulation, June 21, 2005; 111(24): 3327 - 3335. [Full Text] [PDF]

				D. A.M.J. Theuns, A. P. J. Klootwijk, D. M. Goedhart, and L. J.L.M. Jordaens Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2362 - 2367. [Abstract] [Full Text] [PDF]

				D. Bansch, F. Steffgen, G. Gronefeld, C. Wolpert, D. Bocker, R.-U. Mletzko, W. Schols, K. Seidl, M. Piel, F. Ouyang, et al. The 1+1 Trial: A Prospective Trial of a Dual- Versus a Single-Chamber Implantable Defibrillator in Patients With Slow Ventricular Tachycardias Circulation, August 31, 2004; 110(9): 1022 - 1029. [Abstract] [Full Text] [PDF]

				L. Vanhees, M. Kornaat, J. Defoor, G. Aufdemkampe, D. Schepers, A. Stevens, H. van Exel, J. van den Beld, H. Heidbuchel, and R. Fagard Effect of exercise training in patients with an implantable cardioverter defibrillator Eur. Heart J., July 1, 2004; 25(13): 1120 - 1126. [Abstract] [Full Text] [PDF]

				E. Aliot, Rém. Nitzsché, and A. Ripart Arrhythmia detection by dual-chamber implantable cardioverter defibrillators: A review of current algorithms Europace, January 1, 2004; 6(4): 273 - 286. [Abstract] [Full Text] [PDF]

				J. P. DiMarco Implantable Cardioverter-Defibrillators N. Engl. J. Med., November 6, 2003; 349(19): 1836 - 1847. [Full Text] [PDF]

				J. L. Rojo-Alvarez, A. Arenal, A. Garcia-Alberola, M. Ortiz, M. Valdes, and A. Artes-Rodriguez A new algorithm for rhythm discrimination in cardioverter defibrillators based on the initial voltage changes of the ventricular electrogram Europace, January 1, 2003; 5(1): 77 - 82. [Abstract] [PDF]

				R. Ricci, C. Pignalberi, M. Disertori, A. Capucci, L. Padeletti, G. Botto, S. Toscano, F. Miraglia, A. Grammatico, and M. Santini Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias Eur. Heart J., September 2, 2002; 23(18): 1471 - 1479. [Abstract] [Full Text] [PDF]

				E. B. Schron, D. V. Exner, Q. Yao, L. S. Jenkins, J. S. Steinberg, J. R. Cook, S. P. Kutalek, P. L. Friedman, R. S. Bubien, R. L. Page, et al. Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of Therapy and Influence of Adverse Symptoms and Defibrillator Shocks Circulation, February 5, 2002; 105(5): 589 - 594. [Abstract] [Full Text] [PDF]

				R.N.W. Hauer, E. Aliot, M. Block, A. Capucci, B. Luderitz, M. Santini, and P.E. Vardas Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology Eur. Heart J., July 1, 2001; 22(13): 1074 - 1081. [PDF]

				R. N. W. Hauer, E. Aliot, M. Block, A. Capucci, B. Luderitz, M. Santini, and P. E. Vardas Indications for implantable cardioverter defibrillator (ICD) therapy: Study Group on Guidelines on ICD of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology Europace, January 1, 2001; 3(3): 169 - 176. [PDF]

				D. Theuns, A. P. Klootwijk, G. P. Kimman, T. Szili-Torok, J. R. T. C. Roelandt, and L. Jordaens Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators Europace, January 1, 2001; 3(3): 181 - 186. [Abstract] [PDF]

				R Tavernier, S Gevaert, J De Sutter, A De Clercq, H Rottiers, L Jordaens, and W Fonteyne Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias Heart, January 1, 2001; 85(1): 53 - 56. [Abstract] [Full Text]

				K. Glatter and L. B. Liem Implantable Cardioverter Defibrillator: Current Progress and Management Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2000; 4(3): 162 - 179. [Abstract] [PDF]

				D. Bansch, M. Castrucci, D. Bocker, G.u. Breithardt, and M. Block Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: Incidence, prediction and significance J. Am. Coll. Cardiol., August 1, 2000; 36(2): 557 - 565. [Abstract] [Full Text] [PDF]

				T. Korte, W. Jung, G. Ostermann, C. Wolpert, S. Spehl, B. Esmailzadeh, and B. Luderitz Hospital readmission after transvenous cardioverter/defibrillator implantation. A single centre study Eur. Heart J., July 2, 2000; 21(14): 1186 - 1191. [Abstract] [PDF]

				C. Sticherling, A. Schaumann, T. Klingenheben, S. H. Hohnloser, and for the Ventak AV II DR investigators First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator: Advantages and complications Europace, January 1, 1999; 1(2): 96 - 102. [Abstract] [PDF]

				M. Rosenqvist, T. Beyer, M. Block, K. den Dulk, J. Minten, and F. Lindemans Adverse Events With Transvenous Implantable Cardioverter-Defibrillators : A Prospective Multicenter Study Circulation, August 18, 1998; 98(7): 663 - 670. [Abstract] [Full Text] [PDF]

				A. Schaumann, F. v. z. Muhlen, B. Herse, B.-D. Gonska, and H. Kreuzer Empirical Versus Tested Antitachycardia Pacing in Implantable Cardioverter Defibrillators : A Prospective Study Including 200 Patients Circulation, January 13, 1998; 97(1): 66 - 74. [Abstract] [Full Text] [PDF]

				C. D. Swerdlow, C. T. Peter, R. M. Kass, E. S. Gang, W. J. Mandel, C. Hwang, D. J. Martin, and P.-S. Chen Programming of Implantable Cardioverter-Defibrillators on the Basis of the Upper Limit of Vulnerability Circulation, March 18, 1997; 95(6): 1497 - 1504. [Abstract] [Full Text]

				M. Nair, N. Saoudi, D. Kroiss, and B. Letac Automatic Arrhythmia Identification Using Analysis of the Atrioventricular Association: Application to a New Generation of Implantable Defibrillators Circulation, February 18, 1997; 95(4): 967 - 973. [Abstract] [Full Text]

				R. W. Peters, S. McQuillan, S. K. Resnick, and M. R. Gold Increased Monday Incidence of Life-Threatening Ventricular Arrhythmias: Experience With a Third-Generation Implantable Defibrillator Circulation, September 15, 1996; 94(6): 1346 - 1349. [Abstract] [Full Text]

				G. J. Fahy, E. B. Sgarbossa, P. J. Tchou, and S. L. Pinski Hospital Readmission in Patients Treated With Tiered-Therapy Implantable Defibrillators Circulation, September 15, 1996; 94(6): 1350 - 1356. [Abstract] [Full Text]

				A. Garcia-Alberola, S. Yli-Mayry, M. Block, W. Haverkamp, A. Martinez-Rubio, H. Kottkamp, G. Breithardt, and M. Borggrefe RR Interval Variability in Irregular Monomorphic Ventricular Tachycardia and Atrial Fibrillation Circulation, January 15, 1996; 93(2): 295 - 300. [Abstract] [Full Text]

				S. L. Pinski and G. J. Fahy The Proarrhythmic Potential of Implantable Cardioverter-Defibrillators Circulation, September 15, 1995; 92(6): 1651 - 1664. [Abstract] [Full Text]